Data / Drug companies / Gadolinium-based Contrast Agent
Gadolinium-based Contrast Agent drugs: 4 drugs from 9 companies in the FDA NDC directory
Gadolinium-based Contrast Agent is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 39 products in this class from 9 companies, covering 4 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 30, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 9Companies
- 39Products
- 4Drugs by generic name
Drugs in the Gadolinium-based Contrast Agent class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Gadobutrol | 21 | 6 |
| Gadoterate meglumine | 14 | 4 |
| Gadobenate dimeglumine | 2 | 1 |
| Gadoxetate disodium | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Slate Run Pharmaceuticals, LLC | 10 | injection | Generic drugs (ANDA) | April 16, 2025 |
| Fresenius Kabi USA, LLC | 8 | injection | Generic drugs (ANDA) | October 1, 2023 |
| Guerbet LLC | 5 | injection | New drug applications (NDA) | September 18, 2019 |
| Bayer HealthCare Pharmaceuticals Inc. | 4 | injection; injection, solution | New drug applications (NDA) | March 14, 2011 |
| GE Healthcare Inc. | 3 | injection, solution | Generic drugs (ANDA) | September 30, 2026 |
| Viwit Pharmaceutical Co., Ltd. | 3 | injection | Generic drugs (ANDA) | June 11, 2026 |
| Zydus Pharmaceuticals USA Inc. | 3 | injection | Generic drugs (ANDA) | July 14, 2026 |
| Bracco Diagnostics Inc | 2 | injection, solution | New drug applications (NDA) | November 23, 2004 |
| Energique, Inc. | 1 | liquid | Unapproved homeopathic products | February 11, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 32 | 82.1% |
| Injection, solution | 6 | 15.4% |
| Liquid | 1 | 2.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.